Video

Can Pharmacists Dispensing Naloxone Without a Prescription Help Reduce Fatal Outcomes?

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses whether or not allowing pharmacists to dispense naloxone without a prescription can help reduce fatal outcomes.

Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, discusses whether or not allowing pharmacists to dispense naloxone without a prescription can help reduce fatal outcomes.

This video was recorded at APhA's 2016 Annual Meeting and Exhibition in Baltimore, Maryland.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
PCV10 Elicits Durable Immune Response in T2D, Though Response Remains Inferior to Non-Diabetics
April 19th 2025

PCV10 Elicits Durable Immune Response in T2D, Though Response Remains Inferior to Non-Diabetics

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
SPPCP 2025: Highlights and Can't-Miss Sessions From the Virtual Conference on Pain and Palliative Care Pharmacy
April 18th 2025

SPPCP 2025: Highlights and Can't-Miss Sessions From the Virtual Conference on Pain and Palliative Care Pharmacy

Cara M. Brock, PharmD
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Ozempic Insulin injection pen for diabetics. Concept of losing weight with the drug Image credit: Kassandra | stock.adobe.com
April 18th 2025

Study: Vision Impairment Signals Linked to Semaglutide Use

Kennedy Ferruggia, Assistant Editor
People scratch the itch with hand, Elbow, itching, Healthcare And Medicine, Men with skin problem concept
Published: April 18th 2025 | Updated: April 18th 2025

FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria

Luke Halpern, Assistant Editor